US to fully approve Pfizer vaccine next week


US to fully approve Pfizer vaccine next week

The New York Times quoted sources as saying that the US Food and Drug Administration is working to fully approve the Covid-19 vaccine of the Pfizer – BioNTech joint venture on August 23.

Top US health officials say the effectiveness of an mRNA-based Covid-19 vaccine will diminish over time, especially for people with compromised immune systems.

The full approval review process could extend past August 23 if more paperwork is needed and negotiations between Pfizer – BioNTech continue.

If fully approved, ‘s Covid-19 vaccine Pfizer – BioNTech will became the first Covid-19 vaccine to be moved from emergency use authorization to full approval.

Anthony Fauci, the White House’s chief medical adviser, told the Associated Press that he expects the Covid-19 vaccines to begin receiving full approval in August, adding that full approvals are available. will encourage more businesses and schools to use vaccines.

The full approval of the Covid-19 vaccine will be convincing convincing to those who are hesitant to get vaccinated. Before the happenings The number of Covid-19 infections has spiked across the US in the past few weeks, American businesses have tightened regulations on vaccination for employees.

According to data from the US Centers for Disease Control and Prevention, more than 203 million doses of Pfizer – BioNTech vaccine have been used, fully vaccinated for more than 91 million people in the US, as of August 20.

Pfizer and BioNTech initially started the bio-licensing process (to put a biological product into commercial use in the states) for the two-dose Covid-19 vaccine in May 2021 after receiving the license. for emergency use from the US Food and Drug Administration in December 2020. The agency has set a goal of approving high-priority drugs within six months.

CNBC reported that the Covid-19 vaccine developed by the Pfizer – BioNTech joint venture, if officially authorized, will still be distributed on the market even after the pandemic ends and they can live introduce vaccines to consumers. However, for drug manufacturers that have only been approved for emergency use, they will be banned from promoting their vaccines.

Earlier this week, Pfizer and BioNTech said they have begun the process of approving dose increases for people who have had two doses of the vaccine, after submitting clinical trial data to the Food and Drug Administration. America.

In a statement midweek this week, top health officials from The White House, The US Centers for Disease Control and Prevention, and the US Food and Drug Administration jointly agree that the effectiveness of the Covid-19 vaccine using mRNA technology will decrease over time, especially for people with compromised immune systems.

They added that the US will begin to widely distribute the additional vaccine to the general population in September.